stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Elevance Health IncELV
$418.251.73%-7.37

Elevance Health Inc (ELV)

Elevance Health Inc Stock (ELV) Forecast

The Elevance Health Inc (ELV) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $417.29, representing a -0.23% decrease from the current price of $418.25. The highest analyst price target is $440.96, and the lowest is $393.62.

Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month ELV Price Target
Average 429.23 (+2.63% Downside)

Is Elevance Health Inc (ELV) A Buy Now?

Oscillators
NameValueAction
RSI(14)48.64Neutral
STOCH(9,6)39.09Neutral
STOCHRSI(14)7.79Buy
MACD(12,26)3.07Sell
ADX(14)19.22Neutral
William %R-74.08Neutral
CCI(14)-38.65Neutral
Buy: 1 · Sell: 1 · Neutral: 5Summary: Neutral
Moving Averages
PeriodSimpleExponential
MA10
421.54
Sell
423.87
Sell
MA20
427.33
Sell
422.34
Sell
MA50
413.35
Buy
414.57
Buy
MA100
404.08
Buy
403.12
Buy
MA200
373.85
Buy
384.67
Buy
Buy: 6 · Sell: 4 · Neutral: 0Summary: Buy

According to our latest analysis, ELV could be considered a Potential Buy, with 17 technical analysis indicators signaling 7 Buy signals, 5 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on ELV, as trading bullish markets is always a lot easier

  1. RSI (Relative Strength Index): The RSI(14) value of 48.64 indicates that ELV is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 39.09 indicates that ELV is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 7.79 indicates that ELV is oversold. This suggests that ELV price is at or near the lowest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of 19.22 suggests that there may be some movement in price, but it lacks strength or conviction.
  5. CCI (Commodity Channel Index): A CCI(14) value of -38.65 indicates that ELV is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term ELV price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Elevance Health Inc financial reports and earnings history, Elevance Health Inc (ELV) stock could reach $372.66 by 2030, $220.98 by 2040 and $138.15 by 2050. See the projected annual prices until 2050 of the Elevance Health Inc stock below:

  • Elevance Health Inc (ELV) is expected to reach an average price of $194.93 in 2035, with a high prediction of $303.98 and a low estimate of $154.43. This indicates an -53.39% change from the last recorded price of $418.25.
  • Elevance Health Inc (ELV) stock is projected to chart a bullish course in 2040, with an average price target of $203.70, representing an -51.30% change from its current level. The forecast ranges from a conservative $94.80 to a sky-high $220.98.
  • Our analysts predict Elevance Health Inc (ELV) to change -56.10% by 2045, soaring from $35.15 to an average price of $183.59, potentially reaching $184.62. While $35.15 is the low estimate, the potential upside is significant.
  • Elevance Health Inc (ELV) stock is expected to climb by 2050, reaching an average of $128.85, a -69.19% change from its current level. However, a wide range of estimates exists, with high and low targets of $138.15 and $0.3897, respectively, highlighting the market's uncertainty.

Elevance Health Inc Stock (ELV) Year by Year Forecast

Elevance Health Inc Stock (ELV) Price Forecast for 2026

The predicted value for Elevance Health Inc (ELV) in 2026 is set at an average of $376.95. Estimates vary from a peak of $450.69 to a trough of $274.84, indicating an -9.87% surge from the present price of $418.25.

MonthAverageLowHighChange from today's price
December, 2026$437.71$393.62$440.96+4.65%

Elevance Health Inc Stock (ELV) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Elevance Health Inc (ELV) is $420.61, with a high forecast of $484.11 and a low forecast of $364.73. This indicates an +0.56% increase from the last price of $418.25.

MonthAverageLowHighChange from today's price
January, 2027$427.91$408.85$447.20+2.31%
February, 2027$401.51$374.44$432.77-4.00%
March, 2027$461.29$390.16$484.11+10.29%
April, 2027$467.69$408.95$472.03+11.82%
May, 2027$447.91$426.37$478.88+7.09%
June, 2027$427.62$399.62$446.95+2.24%
July, 2027$430.27$405.47$443.90+2.87%
August, 2027$398.57$386.35$432.53-4.70%
September, 2027$420.00$375.75$433.94+0.42%
October, 2027$393.14$379.23$420.37-6.00%
November, 2027$406.03$374.35$417.95-2.92%
December, 2027$365.40$364.73$411.72-12.64%

Elevance Health Inc Stock (ELV) Price Forecast for 2028

In 2028, Elevance Health Inc (ELV) is projected to reach an average price of $422.17, with a high projection of $485.82 and a low estimate of $348.04. This indicates an +0.94% rise from the last price of $418.25.

MonthAverageLowHighChange from today's price
January, 2028$399.36$348.04$417.03-4.52%
February, 2028$378.33$377.53$412.79-9.55%
March, 2028$383.56$370.19$392.37-8.29%
April, 2028$390.38$367.91$419.10-6.66%
May, 2028$399.72$374.12$402.31-4.43%
June, 2028$414.88$396.69$422.55-0.80%
July, 2028$412.21$396.04$425.95-1.44%
August, 2028$432.35$386.15$434.76+3.37%
September, 2028$438.62$423.74$453.98+4.87%
October, 2028$456.09$429.47$458.73+9.05%
November, 2028$474.95$431.22$479.76+13.56%
December, 2028$485.54$456.66$485.82+16.09%

Elevance Health Inc Stock (ELV) Price Forecast for 2029

The 2029 price forecast for Elevance Health Inc Stock (ELV) is $390.12 on average, with a high prediction of $505.69 and a low estimate of $301.24. This represents an -6.73% decrease from the previous price of $418.25.

MonthAverageLowHighChange from today's price
January, 2029$472.43$429.08$488.20+12.95%
February, 2029$438.27$432.31$493.50+4.79%
March, 2029$470.36$436.15$480.22+12.46%
April, 2029$489.30$463.64$505.69+16.99%
May, 2029$430.67$428.76$498.45+2.97%
June, 2029$344.50$336.65$448.91-17.63%
July, 2029$345.88$329.90$372.19-17.30%
August, 2029$310.13$301.24$351.30-25.85%
September, 2029$324.49$303.75$337.63-22.42%
October, 2029$324.48$317.38$354.76-22.42%
November, 2029$366.71$318.03$377.66-12.32%
December, 2029$364.22$329.69$398.35-12.92%

Elevance Health Inc Stock (ELV) Price Forecast for 2030

Elevance Health Inc Stock (ELV) is expected to reach an average price of $283.91 in 2030, with a high forecast of $372.66 and a low forecast of $214.07. This signifies an -32.12% decrease from the last price of $418.25.

MonthAverageLowHighChange from today's price
January, 2030$344.41$341.94$372.66-17.65%
February, 2030$333.34$297.32$364.11-20.30%
March, 2030$329.08$309.88$334.27-21.32%
April, 2030$223.37$214.66$340.68-46.59%
May, 2030$256.98$214.07$259.65-38.56%
June, 2030$254.28$244.66$266.16-39.20%
July, 2030$289.52$251.61$305.58-30.78%
August, 2030$266.72$241.70$296.57-36.23%
September, 2030$281.76$252.80$304.57-32.63%
October, 2030$314.04$280.10$320.81-24.92%
November, 2030$280.33$256.77$324.24-32.98%
December, 2030$233.15$216.36$293.42-44.26%

Similar to ELV